Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideya Yamazaki

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
Journal of Radiation Research|April 10, 2012
Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinationsTadashi Takenaka, Ken Yoshida, Mari Ueda, et al.
Journal of Radiation Research|January 14, 2012
Interstitial brachytherapy using virtual planning and Doppler transrectal ultrasonography guidance for internal iliac lymph node metastasisKen Yoshida, Mari Ueda, Hideya Yamazaki, et al.
Case Reports in Oncology|July 12, 2021
Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and ChemotherapyToru Matsugasumi, Koji Masui, Kaori Yamada, et al.
Anticancer Research|February 9, 2013
Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapyHideya Yamazaki, Satoaki Nakamura, Kana Kobayashi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 20, 2014
High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer: are high-risk patients good candidates?Ken Yoshida, Hideya Yamazaki, Tadashi Takenaka, et al.
Cureus|June 14, 2024
The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving SurgeryAkihiro Nakashima, Hideya Yamazaki, Gen Suzuki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2018
Comparison of three moderate fractionated schedules employed in high-dose-rate brachytherapy monotherapy for clinically localized prostate cancerHideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Tumori|October 28, 2009
Assessment of influence of smoking, drinking, leukoplakia and dental irritation on local control of early oral tongue carcinoma treated with brachytherapy: age and dental factors are potential prognostic factorsHideya Yamazaki, Takehiro Inoue, Ken Yoshida, et al.
Journal of Radiation Research|July 31, 2012
Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancerHironori Akiyama, Ken Yoshida, Kimishige Shimizutani, et al.
Cancer Diagnosis & Prognosis|November 7, 2022
Palliative Radiation Therapy for Intramedullary Spinal Cord MetastasisTakeshi Nishimura, Hideya Yamazaki, Gen Suzuki, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
Journal of Radiation Research|April 10, 2012
Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinationsTadashi Takenaka, Ken Yoshida, Mari Ueda, et al.
Journal of Radiation Research|January 14, 2012
Interstitial brachytherapy using virtual planning and Doppler transrectal ultrasonography guidance for internal iliac lymph node metastasisKen Yoshida, Mari Ueda, Hideya Yamazaki, et al.
Case Reports in Oncology|July 12, 2021
Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and ChemotherapyToru Matsugasumi, Koji Masui, Kaori Yamada, et al.
Anticancer Research|February 9, 2013
Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapyHideya Yamazaki, Satoaki Nakamura, Kana Kobayashi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 20, 2014
High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer: are high-risk patients good candidates?Ken Yoshida, Hideya Yamazaki, Tadashi Takenaka, et al.
Cureus|June 14, 2024
The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving SurgeryAkihiro Nakashima, Hideya Yamazaki, Gen Suzuki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2018
Comparison of three moderate fractionated schedules employed in high-dose-rate brachytherapy monotherapy for clinically localized prostate cancerHideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Tumori|October 28, 2009
Assessment of influence of smoking, drinking, leukoplakia and dental irritation on local control of early oral tongue carcinoma treated with brachytherapy: age and dental factors are potential prognostic factorsHideya Yamazaki, Takehiro Inoue, Ken Yoshida, et al.
Journal of Radiation Research|July 31, 2012
Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancerHironori Akiyama, Ken Yoshida, Kimishige Shimizutani, et al.
Cancer Diagnosis & Prognosis|November 7, 2022
Palliative Radiation Therapy for Intramedullary Spinal Cord MetastasisTakeshi Nishimura, Hideya Yamazaki, Gen Suzuki, et al.
Pageof 22